王强，硕士研究生，副教授，硕士生导师
邮箱：wqiang_1981@126.com
研究方向：1.临床免疫检验常见问题的解决方案
2.肝细胞肝癌的早期诊断研究
3.自身免疫性疾病发病机制研究
个人简介
1999.09-2004.07，重庆医科大学医学检验系本科学习
2004.07-2006.08，重庆市长寿区疾控中心检验科工作
2006.09-2009.07，重庆医科大学临床检验诊断学攻读硕士研究生
2009.07至今，川北医学院医学检验系工作
承担的课题
新医科背景下的临床免疫学检验技术临床循证思维能力培养模式的构建（教育部产学研协同育人项目，220906160193826）
2019-nCoV血清抗体GICA确诊检测体系研究（南充市市校科技战略合作专项，20SXQT0337）
科研成果
第一作者和通讯作者在Journal of Clinical Microbiology，Clinica Chimica Acta，中华检验医学杂志和病毒学报等期刊发表科研论文20余篇，其中SCI论文16篇。
1. A Method To Prevent SARS-CoV-2 IgM False Positives in Gold Immunochromatography and Enzyme-Linked Immunosorbent Assays. Journal of Clinical Microbiology, 2020, 58(6): e00375-20. (第一作者)
2. Mechanism of heparin interference in detection of LIAISON® Rubella IgM. Clin Chim Acta. 2020, 511: 7-13. (第一作者)
3. Diagnostic value of the γ-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma. Scientific Reports, 2020, 10(1): 13519. (通讯作者)
4. A simple formula to correct for the effects of storage time and temperature on the insulin concentration. J Clin Lab Anal, 2020, 34(7): e23255. (通讯作者)
5. A method to alleviate false-positive results of the Elecsys HIV combi PT assay. Scientific Reports, 2021, 11(1): 1033. (通讯作者)
6. Construction and validation of NSMC-ASIL, a predictive model for risk assessment of malignant hepatic nodules. Am J Cancer Res, 2022, 12(11): 5315-5324. (通讯作者)
7. A Novel Diagnostic Model for Early Hepatitis B Virus-Related Hepatocellular Carcinoma Diagnosis. Clinical Laboratory, 2023, 69: 99-111. (通讯作者)
8. Serum proteomics unveil characteristic protein diagnostic biomarkers and signaling pathways in patients with esophageal squamous cell carcinoma. Clinical Proteomics, 2022, 19(1): 18. (共同第一作者)
9. Metabolic pathways underlying GATA6 regulating Trastuzumab resistance in Gastric Cancer cells based on untargeted metabolomics. Int J Med Sci, 2020, 17(18): 3146-3164. (共同第一作者)
10. Distribution characteristics of SARS-CoV-2 IgM/IgG in false-positive results detected by chemiluminescent immunoassay. Open Life Sci, 2022, 17(1): 1487-1496. (通讯作者)
11. Establishment of a quantitative detection method for magnetic microparticle chemiluminescence of anti-SSA-60 antibody. Clinica Chimica Acta, 2019, 495: 77-81. (共同第一作者)
12. Urea-mediated dissociation alleviate the false-positive Treponema pallidum-specific antibodies detected by ELISA. PLoS ONE, 2019, 14(3): e0212893. (第一作者)
13. A correction formula for neuron-specific enolase measurement in hemolyzed neonatal serum samples. Biomedical Reports, 2018, 8(5): 491-496. (第一作者)
14. miR-27a promotes hemin-induced erythroid differentiation of K562 cells by targeting CDC25B. Cellular Physiology and Biochemistry, 2018, 46: 365-374. (共同第一作者)
15. Diagnostic value of γ-GT/AST ratio, PIVKA-II and AFP in hepatitis B virus-related hepatocellular carcinoma. World Journal of Gastroenterology, 2019, 25(36): 5515-5529. (第一作者)
16. Global metabolomic profiling of trastuzumab resistant gastric cancer cells reveals major metabolic pathways and metabolic signatures based on UHPLC-Q exactive-MS/MS. RSC Advances, 2019, 9(70): 41192-41208. (共同第一作者)
17. 尿素解离法纠正2019新型冠状病毒IgM抗体检测结果假阳性的效果评价. 中华检验医学杂志. 2020, 43(9): 889-893. (第一作者)
18. 尿素解离法降低新型冠状病毒IgM 和IgG 检测结果假阳性的效果评价. 病毒学报. 2020, 36(4): 570-577. (通讯作者)
19. GICA 和CLIA 联合检测SARS-CoV-2特异性抗体的检测策略研究. 病毒学报. 2022, 38(1):21-27. (通讯作者)
